EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...

(RTTNews) - Immuneering Corp. (IMRX), Tuesday announced positive data update from three arms of its ongoing Phase 2a trial of lead program IMM-1-104 for the treatment of patients with Pancreatic ...

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies ...

Blood test shows promising results in detecting cancer early, study says - The so-called liquid biopsy analyses DNA in the ...

(Alliance News) - Diaceutics PLC on Wednesday said it has launched its new pathology engagement liaisons service, and secured a new 12-month contract worth up to USD1.8 million.

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Results from the Mariposa study found a regimen of Rybrevant and Lazcluze helped patients with a common form of advanced lung ...

Johnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...